Holdings
BML Capital Management, LLC
As of Jun 30, 2026, BML Capital Management, LLC reported 14 positions worth US$164M. Largest: Aclaris Therapeutics, Inc., Atea Pharmaceuticals, Inc. and The Kraft Heinz Company. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Aclaris Therapeutics, Inc. | 12M | US$63.3M | −2.27M | Jun 30, 2026 |
| Atea Pharmaceuticals, Inc. | 6.95M | US$32.3M | −106K | Jun 30, 2026 |
| The Kraft Heinz Company | 465K | US$11M | +340K | Jun 30, 2026 |
| Outset Medical, Inc. | 2.52M | US$10.9M | +618K | Jun 30, 2026 |
| Carmax Inc | 173K | US$9.12M | +17,500 | Jun 30, 2026 |
| Tilly's, Inc. | 2.15M | US$9.03M | no change | Jun 30, 2026 |
| Pmv Pharmaceuticals, Inc. | 5.33M | US$7.14M | +10,000 | Jun 30, 2026 |
| Instil Bio, Inc. | 646K | US$4.96M | no change | Jun 30, 2026 |
| Target Corporation | 37,500 | US$4.9M | no change | Jun 30, 2026 |
| Oramed Pharmaceuticals Inc. | 866K | US$4.17M | −2.3M | Jun 30, 2026 |